共 17 条
[1]
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The LIPID Study Group. The New England Journal of Medicine . 1998
[2]
Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. ANTMAN EM,TANASIJEVIC MJ,THOMPSON B,et al. The New England Journal of Medicine . 1996
[3]
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) ⅡB trial. ANTMAN EM,MCCABE CH,GUEFINKEL EP,et al. Circulation . 1999
[4]
Guidelines for the diagnosis and management of unstable angina and non-Q-wave myocardial infarction:proposed revisions. ANTMAN EM,FOX KM. American Heart Journal . 2000
[5]
A randomised, blinded trial of clopidogrel versus aspirin in patients at high risk of ischemic events(CAPRIE). CAPRIE Steering Committee. The Lancet . 1996
[6]
Cardiac troponin T levels for risk stratification in acute myocardial ischemia. OHMAN EM,ARMSTRONG PW,CHRISTENSON RH,et al. The New England Journal of Medicine . 1996
[7]
Inhibition of the platelet glycoprotein Ⅱb/Ⅲa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. The PRISM-PLUS Study Investigators. The New England Journal of Medicine . 1998
[8]
Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia. GURFINKEL EP,MANOS EJ,MEJAIL RI,et al. Journal of the American College of Cardiology . 1995
[9]
Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI ⅢB trial. The TIMI ⅢB Investigators. Circulation . 1994
[10]
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. LEAN MB,BAIM DS,POPMA JJ,et al. The New England Journal of Medicine . 1998